Share this post on:

Product Name :
Cis-urocanic acid

Search keywords :
Urocanic acid

drugId :
null

Target Vo:
Interleukin-6

Target Vo Short Name :
IL6

Moa_Name:
Interleukin-6 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Herantis Pharma

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Urinary Bladder Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOX1 Rabbit mAb Epigenetic Reader Domain
Relatlimab site
Pan Cytokeratin Antibody: Pan Cytokeratin Antibody is an unconjugated, approximately 42-64 kDa, rabbit-derived, anti-Pan Cytokeratin polyclonal antibody. Pan Cytokeratin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, cow, and predicted: chicken, dog, pig, horse, rabbit background without labeling.

Share this post on:

Author: Interleukin Related